Navigation Links
FDA Lifts Injunction on Manufacture and Sale of CareFusion Alaris(R) SE Pump
Date:1/11/2010

SAN DIEGO, Jan. 11 /PRNewswire-FirstCall/ -- CareFusion (NYSE: CFN), a leading, global medical device company, announced today that the Food and Drug Administration (FDA) has given the company permission to resume manufacturing and marketing the Alaris® SE line of infusion pumps (also known as the Signature Edition® infusion pump).

CareFusion, formerly the Clinical and Medical Products division of Cardinal Health, has been operating under a consent decree with the FDA since February 2007. The consent decree included an injunction on the manufacture and sale of the Alaris SE pump. The FDA recently notified CareFusion that the injunction has been lifted, allowing the company to resume sales of the Alaris SE pump.

"We have worked diligently over the past several years to improve our quality system and to complete the necessary steps to resume the production, sale and installation of the Alaris SE pump," said David Schlotterbeck, chairman and CEO of CareFusion. "While we still have work to do under our consent decree, we are pleased to have reached this important milestone."

About CareFusion Corporation

CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® IV pumps, Pyxis® automated dispensing and patient identification systems, AVEA® and Pulmonetic Systems ventilation and respiratory products, ChloraPrep® products, MedMined(TM) services for infection surveillance, NeuroCare neurological monitoring and diagnostic products, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 15,000 people across its global operations. More information may be found at www.carefusion.com.

SOURCE CareFusion Corporation

RELATED LINKS
http://www.carefusion.com

'/>"/>

SOURCE CareFusion Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Lifts Clinical Hold on Gentas Tesetaxel, a Leading Oral Taxane
2. New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties
3. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
4. Celltrion and CSL Announce Collaboration to Develop and Manufacture Monoclonal Antibody
5. Infant Formula Manufacturers Again under Ethical Cloud: Marketing Gimmick Linked to Serious Illnesses
6. Grocery Manufacturers Association: Study Signals Progress in Battle Against Obesity
7. Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells
8. QRxPharma Inks Deal with Patheon for the Manufacture of MoxDuo(TM)CR
9. Eclipse Announces Partnership with Human Med USA, Manufacturers of Revolutionary Body-Jet(R)
10. Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand
11. China Medicine Corporation to Acquire Pharmaceutical Manufacturer in Guangzhou
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... announced the addition of the "Rheumatoid Arthritis Drugs Price Analysis and ... latest research Rheumatoid Arthritis Drugs Price Analysis and Strategies - 2016, provides ... The research answers the following questions: ... attributes? How are they positioned in the Global Rheumatoid Arthritis market? ...
(Date:2/28/2017)... 2017 Medical robots market is projected to ... billion in 2016, growing at a CAGR of 21.1% ... Read the full report: http://www.reportlinker.com/p04730562-summary/view-report.html ... therapy, technological advancements, increase in funding for medical robots ... growing hospital investments are the key factors driving the ...
(Date:2/28/2017)... , Feb. 27, 2017  Summary This ... understand Syngenta and its partnering interests and activities since ... Description The Partnering Deals and Alliance ... partnering activity of one of the world,s leading life ... prepared upon purchase to ensure inclusion of the most ...
Breaking Medicine Technology:
(Date:2/28/2017)... City, Utah (PRWEB) , ... February 28, 2017 , ... ... is a time for everyone to reaffirm their commitment to improving cardiovascular health for ... of death for men and women. Every year, one in four deaths are caused ...
(Date:2/27/2017)... WI (PRWEB) , ... February 27, 2017 , ... Bo ... Investigator Award. Dr. Chen will receive his award during the Plenary Session at ASLMS ... (ASLMS), to be held in San Diego, California April 5-9, 2017. , During ...
(Date:2/27/2017)... ... 27, 2017 , ... Much attention has been paid to the problem of ... opioid painkillers has fallen short. From 1999 until 2010, fatal overdoses from prescription pain ... overdoses in male populations.(1) , The proportion of women using illicit drugs is also ...
(Date:2/27/2017)... Shenzhen, China (PRWEB) , ... February 26, 2017 , ... ... , This pioneer sound and video system brings songs, movies, TV shows and much ... 3D sound offers clear, high-definition sound. An immersive view of 1280 x 720 provides ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... Francisco and environs, is proud to announce an upgrade to the company's Yelp ... upgraded Yelp page on topics as diverse as Platelet Rich Plasma (PRP) therapy, ...
Breaking Medicine News(10 mins):